A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

Clinical trial NCT01975701 · COMPLETED

Trial details

NCT number: NCT01975701
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma or Other Glioma Subtypes

Start date: 2013-12-09
Primary completion: 2018-10-03
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.